Cellectis S.A. (CLLS)
NASDAQ: CLLS · IEX Real-Time Price · USD
2.300
+0.250 (12.20%)
At close: Jul 26, 2024, 4:00 PM
2.280
-0.020 (-0.87%)
After-hours: Jul 26, 2024, 7:05 PM EDT
Cellectis Market Cap
Cellectis has a market cap or net worth of $135.66 million as of July 26, 2024. Its market cap has increased by 6.57% in one year.
Market Cap
135.66M
Enterprise Value
-66.74M
1-Year Change
6.57%
Ranking
Category
Stock Price
$2.30
Market Cap Chart
Since March 25, 2015, Cellectis's market cap has decreased from $1.34B to $135.66M, a decrease of -89.91%. That is a compound annual growth rate of -21.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 147.20M | -14.02% |
| Dec 29, 2023 | 171.20M | 78.89% |
| Dec 30, 2022 | 95.70M | -74.09% |
| Dec 31, 2021 | 369.30M | -67.88% |
| Dec 31, 2020 | 1.15B | 58.27% |
| Dec 31, 2019 | 726.40M | 2.87% |
| Dec 31, 2018 | 706.10M | -31.45% |
| Dec 29, 2017 | 1.03B | 72.73% |
| Dec 30, 2016 | 596.30M | -43.80% |
| Dec 31, 2015 | 1.06B | -21.04% |
| Mar 25, 2015 | 1.34B | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zomedica | 146.50M |
| Capricor Therapeutics | 145.51M |
| Assertio Holdings | 144.59M |
| Rani Therapeutics Holdings | 143.70M |
| Harvard Bioscience | 141.15M |
| Elevation Oncology | 139.87M |
| Myomo | 139.75M |
| X4 Pharmaceuticals | 139.67M |